DLH Holdings Corp. quarterly report, Q3 FY2016

DLH Holdings Corp. — Form 10-Q, Quarter Ended June 30, 2016

Business context and reporting period

DLH provides healthcare, human-services, and related technology services to U.S. government agencies. The filing covers the fiscal third quarter and first nine months of fiscal 2016. On May 3, 2016, DLH acquired Danya International, a provider of technology-enabled program management, consulting, and digital communications services. Danya’s results are included from the acquisition date.

Financial results and liquidity

MetricThree months ended June 30Nine months ended June 30
Revenue, 2016 / 2015$25.0M / $16.8M$58.5M / $48.4M
Gross margin, 2016 / 2015$5.5M / $3.0M; 21.8% / 18.1% of revenue$11.6M / $8.3M; 19.8% / 17.2% of revenue
Operating income, 2016 / 2015$1.7M / $0.8M$2.7M / $1.5M
Net income, 2016 / 2015$0.8M / $0.4M$1.0M / $0.5M
Diluted EPS, 2016 / 2015$0.07 / $0.04$0.09 / $0.05

Revenue grew 48.9% in the quarter and 20.9% year to date, primarily reflecting Danya and growth on existing contracts. Management cited improved contract performance, cost management, and Danya’s contribution for higher gross margins. Adjusted EBITDA, a non-GAAP measure, was $2.1M for the quarter and $3.6M year to date, versus $0.8M and $2.0M, respectively.

For the nine months, operating cash flow was $3.4M. Investing cash flow was negative $32.7M, mainly due to the acquisition; financing cash flow was positive $26.6M. Cash declined $2.7M to $2.8M. At June 30, current assets were $12.4M and current liabilities $16.0M, producing a $3.6M working-capital deficit. Debt obligations had a $26.5M carrying value, including $24.2M net bank debt and $2.3M net subordinated debt. Revolver availability was $4.3M, subject to eligible receivables and facility conditions.

Material changes, outlook, and risks

  • Danya was purchased for a preliminary $38.75M. Consideration included $30.0M in senior borrowings, $2.5M in subordinated debt, $2.5M in DLH shares, and cash. Purchase-price allocation remained provisional; reported goodwill and other intangibles increased substantially. Danya contributed approximately $7.3M revenue and $0.9M operating income after acquisition.
  • Management said cash, eligible revolver capacity, and expected operating cash flow should support operations for 12 months from the financial-statement date. No specific earnings or revenue guidance was provided. DLH reported compliance with its debt covenants; the facilities include financial tests, restrictions, and excess-cash-flow prepayment requirements.
  • All revenue is from federal agencies. The VA accounted for about 83% of nine-month revenue, down from 95% a year earlier; HHS represented 13%, following Danya. The VA pharmacy mail-order contract was expected to recompete for a new five-year term beginning in November 2016. Losing or materially reducing major VA or HHS work could harm results, cash flow, and financial condition.
  • Wynnefield-affiliated entities, then beneficial owners of approximately 45% of DLH, provided the $2.5M subordinated loan and received warrants. The loan may mature early following an equity financing of at least $2.5M; a rights offering was underway. The filing also reports a consulting agreement with Danya’s former owner at $10,000 per month.
  • Management reported no material litigation expected to adversely affect the company and stated that disclosure controls were effective. Integration of Danya into internal controls was ongoing.

Investor verification points

  • Track the VA contract recompete, renewal timing, and any changes in customer concentration or contract revenue.
  • Review Danya’s post-acquisition performance, integration, final purchase-price allocation, and goodwill/intangible-asset valuation.
  • Monitor working capital, operating cash conversion, revolver availability, debt amortization, covenant compliance, and any required excess-cash-flow payments.
  • Confirm the status and terms of the rights offering and any resulting early repayment of related-party subordinated debt.
  • Reconcile reported GAAP results with Adjusted EBITDA and its exclusions, including acquisition costs, interest, and equity compensation.